BioSpace News Archive

Recros Medica, Inc. today announced the addition of Charlie Huiner and Mitch Levinson to the company’s Board of Directors. Recros Medica is an aesthetic company focused on developing medical devices to reduce skin laxity and improve focal contouring via its Nuvellus® Focal Contouring system. The Nuvellus® platform, based on the co

New, innovative therapy brings breakthrough science and clinical evidence to nutrition Helps patients with malabsorption meet their weight and nutritional needs

Sacubitril-valsartan (Entresto®) has been proven to decrease hospitalization and reduce death due to heart failure with reduced ejection fraction (HFrEF) also known as systolic heart failure

Ezra, the NY-based startup transforming early cancer screening using MRI, announced today that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting r

Celdara Medical announced the launch of the Pandemic Security Initiative’s Scientific Advisory Board, a group of outstanding scientists and infectious disease experts.

Dr. Michael Anderson joins Aveshka as full-time consultant to provide support from a pediatric perspective to the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR).

Caresyntax, a pioneer in surgical automation, analytics, and AI software and technologies, and the Association of periOperative Registered Nurses have partnered to launch a performance guarantee program for their operational analytics solution to make operating rooms more efficient.

The JV InvenTeams Green Chemistry Activity Guide encourages students to use green chemistry principles to invent bioplastics.

Masimo (NASDAQ: MASI) will release third quarter 2020 financial results for the period ended September 26, 2020, after the market closes on Tuesday, October 27, 2020. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive V

GE Healthcare today announced the availability of Serena Bright™ in the United States. Serena Bright™ is the industry’s first contrast-enhanced guided biopsy solution and will help empower clinicians and patients in their fight against breast cancer.